Antithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry

• Κύριοι συγγραφείς: Jun Young Lee (Συγγραφέας), Sung Hwa Kim (Συγγραφέας), Yeon Ho Park (Συγγραφέας), Jae Berm Park (Συγγραφέας), Su Hyung Lee (Συγγραφέας), Jaeseok Yang (Συγγραφέας), Myoung Soo Kim (Συγγραφέας), Deok Gie Kim (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: The Korean Society of Nephrology, 2022-09-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Background Basiliximab (BSX) and antithymocyte globulins (ATGs), are two major immunosuppressive agents commonly used as induction therapy for kidney transplant (KT) recipients. The superiority of ATG over BSX has not been well established, especially in elderly KT recipients with low immunological...